Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience.
De-la-Cruz-Ku G, Luyo M, Morante Z, Enriquez D, Möller MG, Chambergo-Michilot D, Flores L, Luque R, Saavedra A, Eyzaguirre-Sandoval ME, Luján-Peche MG, Noel N, Calderon H, Razuri C, Fuentes HA, Cotrina JM, Neciosup SP, Araujo J, Lema A, Pinto J, Gomez HL, Valcarcel B. De-la-Cruz-Ku G, et al. Among authors: neciosup sp. PLoS One. 2020 Aug 24;15(8):e0237811. doi: 10.1371/journal.pone.0237811. eCollection 2020. PLoS One. 2020. PMID: 32833983 Free PMC article.
Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma: a phase II trial showing reduction in toxicity without altering long-term survival.
Gómez HL, Samanéz C, Campana F, Neciosup SP, Vera L, Casanova L, Leon J, Flores C, de Mendoza FH, Casteñeda CA, Pinto JA, Vallejos CS. Gómez HL, et al. Among authors: neciosup sp. Hematol Oncol Stem Cell Ther. 2012;5(3):152-7. doi: 10.5144/1658-3876.2012.152. Hematol Oncol Stem Cell Ther. 2012. PMID: 23095791 Free article. Clinical Trial.
PIK3CA mutations in Peruvian patients with HER2-amplified and triple negative non-metastatic breast cancers.
Castaneda CA, Lopez-Ilasaca M, Pinto JA, Chirinos-Arias M, Doimi F, Neciosup SP, Rojas KI, Vidaurre T, Balko JM, Arteaga CL, Gomez HL. Castaneda CA, et al. Among authors: neciosup sp. Hematol Oncol Stem Cell Ther. 2014 Dec;7(4):142-8. doi: 10.1016/j.hemonc.2014.09.007. Epub 2014 Oct 29. Hematol Oncol Stem Cell Ther. 2014. PMID: 25467032 Free article.
A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study).
Gómez HL, Neciosup S, Tosello C, Mano M, Bines J, Ismael G, Santi PX, Pinczowski H, Nerón Y, Fanelli M, Fein L, Sampaio C, Lerzo G, Capó A, Zarba JJ, Blajman C, Varela MS, Martínez-Mesa J, Werutsky G, Barrios CH. Gómez HL, et al. Clin Breast Cancer. 2016 Feb;16(1):38-44. doi: 10.1016/j.clbc.2015.10.005. Epub 2015 Nov 10. Clin Breast Cancer. 2016. PMID: 26642810 Free article. Clinical Trial.
Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer.
Saravia CH, Flores C, Schwarz LJ, Bravo L, Zavaleta J, Araujo J, Neciosup S, Pinto JA. Saravia CH, et al. Clin Med Insights Oncol. 2019 Aug 9;13:1179554919868482. doi: 10.1177/1179554919868482. eCollection 2019. Clin Med Insights Oncol. 2019. PMID: 31447598 Free PMC article.
41 results